Download Paper
Yannick Baschung, PhD, has more than eight years of experience in chemistry, manufacturing and controls activities, including five years in orally inhaled and nasal drug product (OINDP) development and analytical services. Currently, he is leading the drug delivery and physical characterization services at Solvias, where he has accompanied several inhaled products from early clinical phase to successful commercial launch. Dr Baschung is a member of the EDQM inhalation working group and holds a PhD in Biomedical Mass Spectrometry. His interests include formulation, aerosol science and drug-device combination products.